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Current mass vaccination campaigns in measles outbreak response are nonselective with respect to the immune
status of individuals. However, the heterogeneity in immunity, due to previous vaccination coverage or infection,
may lead to potential bias of such campaigns toward those with previous high access to vaccination and may result
in a lower-than-expected effective impact. During the 2010 measles outbreak in Malawi, only 3 of the 8 districts
where vaccination occurred achieved a measureable effective campaign impact (i.e., a reduction in measles
cases in the targeted age groups greater than that observed in nonvaccinated districts). Simulation models suggest
that selective campaigns targeting hard-to-reach individuals are of greater benefit, particularly in highly vaccinated
populations, even for low target coverage and with late implementation. However, the choice between targeted and
nonselective campaigns should be context specific, achieving a reasonable balance of feasibility, cost, and
expected impact. In addition, it is critical to develop operational strategies to identify and target hard-to-reach
individuals.
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The World Health Organization (Geneva, Switzerland)
guidelines for response to measles outbreaks in countries
with mortality reduction goals recommend vaccination cam-
paigns as an effective control measure. If there are sufﬁcient
resources and a high risk of a large outbreak, campaigns
should be nonselective with respect to the immune status of
individuals (1). The underlying arguments for nonselective
campaigns are both logistical and medical. The speed of
response is a critical determinant of the success of an out-
break response (2), and the vaccination status of children is
seldom known because of weak or absent vital registration
systems and public health infrastructure. Nonselective cam-
paigns, which do not require veriﬁcation of vaccination sta-
tus, facilitate swift implementation of the intervention. In
addition, nonselective campaigns provide a second-dose
opportunity for those who failed to seroconvert after the
ﬁrst dose.
A necessary consequence of nonselective vaccination is
that a portion of vaccine doses will be delivered to individuals
who are already immune because of a previous vaccination or
infection (L. Grout, Epicentre, unpublished data, 2011).
Under the assumption that immune and nonimmune individ-
uals are vaccinated in proportion to their representations in a
population, the coverage of nonimmune individuals should
equal the population coverage for a nonselective campaign.
However, even nonselective campaigns may preferentially
favor those with high access to vaccination or willingness
to be vaccinated (3). In that event, the effective coverage of
a nonselective campaign (i.e., the coverage of nonimmune
individuals) will be less than or equal to the population cov-
erage of the campaign. Understanding the potential impact of
this interaction between heterogeneity in immunity and the
potential bias in vaccination during campaigns is critical to
predicting the impact of campaigns.
Heterogeneity of access to vaccination and the likelihood
of vaccination during nonselective campaigns confound
efforts to quantify the remaining susceptible population and
subsequent outbreak risk. The distribution of hard-to-reach
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individuals and groups with low immunity within a popula-
tion is difﬁcult to assess a priori. Some low-immunity com-
munities may be easily identiﬁable (e.g., groups with low
physical access to health care or those who refuse vaccination
for religious or cultural reasons (4, 5)). However, heterogene-
ity may also arise because of suboptimal measles control pro-
grams, allowing the progressive building-up of unprotected
individuals. This may be particularly likely in low-transmission
settings, where natural infection contributes little to the dis-
tribution of immunity.
Although Malawi has had low measles incidence since the
early 1990s, a large measles outbreak occurred there in 2010.
Outbreak response was conducted by the Ministry of Health
with the support of Médecins Sans Frontières (MSF) and
included reinforced surveillance, case management, and non-
selective mass vaccination campaigns for children aged 6
months to 15 years in 8 of the 28 districts of the country (dur-
ing weeks 18–26 in 2010) (6). Further, the Ministry of Health
implemented a nationwide nonselective mass vaccination
campaign for children aged 9 months to 15 years (during
weeks 33–34 in 2010). Previously, model-based methods
have been used to estimate the number of measles cases
averted through targeted outbreak response vaccination in a
setting with lowmeasles vaccine coverage (2). Here, we eval-
uate the effective impact of the Ministry of Health/MSF cam-
paign in Malawi in terms of the estimated coverage of the
nonimmunized population. We then use simulation models
to explore the efﬁciency of a nonselective campaign versus
targeted vaccination in populations with heterogeneous ac-
cess to mass vaccination campaigns.
MATERIALS AND METHODS
Estimating effective campaign impact
The coverage of vaccination campaigns is conventionally
assessed through administrative coverage (i.e., the number of
doses administered divided by the target population). How-
ever, in populations that are partially immune because of
either prior vaccination or prior natural exposure, the more
relevant measure of the impact of vaccination campaigns is
the proportion of the remaining susceptible population that
was immunized by the campaign. We deﬁne this proportion
as the “effective impact” of the campaign.
In contexts with large-scale outbreak response interven-
tions for measles, the effective impact is difﬁcult to measure
directly because the immune status of vaccinees is rarely
known, nor is the size of the susceptible population known.
However, for age-targeted campaigns, we would expect a
greater reduction in incidence in the target age classes than
in the nontargeted age classes. If the effective impact were
100%, then we would expect to see few cases in the targeted
age classes after the campaign. Following this logic, we can
use the relative magnitude of the change in targeted and non-
targeted incidence to derive a measurement of the effective
impact of campaigns. This derivation is analogous to prior
estimators of vaccine effectiveness in vaccinated and unvac-
cinated populations (7–9), though here, the unvaccinated and
vaccinated populations are separated in time (before and after
the campaign).
Consider a population with A individuals in the targeted
age class and B individuals in the nontargeted age class.
Though these numbers may be known, the numbers of sus-
ceptible individuals in these age groups, A′ and B′, respec-
tively, are likely to be unknown. Consider further that the
attack rate (cases per 100) in age class A is p, and the attack
rate in age class B is q. Then, at any point in the epidemic
before vaccination, the observed ratio of cases, CR, in age
classes A and B is
CRbefore ¼ pAqB : ð1Þ
Consider a vaccination campaign targeting only individuals
in age class A, that immunizes a fraction, θ, of the susceptible
individuals. Note that θ is the fraction immunized, not the
fraction vaccinated, and thus incorporates the product of cov-
erage and the probability of generating a protective immune
response. If we assume that the attack rates in the remaining
susceptible individuals in groups A and B do not change, then
the observed ratio of cases in age classes A and B after the
campaign should be
CRafter ¼ ð1 θÞpA
0
qB0
: ð2Þ
We can then solve for the effective proportion of the suscep-
tible individuals in A′ who were immunized in terms of the
observed ratios of cases before and after the campaign as
CRafter
CRbefore
¼ ð1 θÞð pA
0=qB0Þ
pA0=qB0
: ð3Þ
If we make the simplifying assumption that the attack rates in
classes A and B are the same before and after the vaccination
campaign, then we can estimate θ on the basis of the observed
ratios of cases before and after the campaign as follows:
θ ¼ 1 CRafter
CRbefore
: ð4Þ
By using equation 4, we estimated the effective impact of
vaccination campaigns conducted in 8 districts of Malawi
during the 2010 outbreak. Between weeks 18 and 26 of
2010, more than 3.3 million individuals aged 6 months to
15 years were vaccinated, achieving overall vaccine coverage
of 95.5%. Measles vaccine coverage, as estimated by post-
campaign surveys, ranged from 92.3% in Mzimba to 98.0%
in Chiradzulu. Between weeks 1 and 52 of 2010, a total of
134,039 measles cases and 304 deaths were reported, with
42% of all cases in children younger than 5 years, 30% in
those aged 5–14 years, and 28% in adults aged 15 years or
older. The overall cumulative attack rate was 0.96%, and
the case fatality rate was 0.23% (6).
The calculations in equation 4 assume that the age-speciﬁc
attack rates are the same before and after the campaign. As
observed by Haber et al. (8), violation of this assumption can
lead to biased estimates. Here, there are 2 ways in which this
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assumption may be violated. The ﬁrst is if, in the absence of
the campaign, the epidemic would have exhausted suscepti-
bles in 1 group faster than in the other. This is challenging to
assess in the absence of observed data from a noncampaign
setting. During the 2010 Malawi outbreak, the nationwide
surveillance system allowed for evaluation of the age-speciﬁc
attack rates. In districts in whichMSF did not intervene (20 of
28 districts), we can assess the ratio, CRafter / CRbefore, for any
reference week in the epidemic (Figure 1A). Though the ratio
of cases before and after the reference week is highly variable
early and late in the epidemic because of low numbers of
cases, the ratio during the central portion of the outbreak was
very near 1 for noncampaign districts. This suggests that, for
the 2010 outbreak in Malawi, the relative age-speciﬁc attack
rates late in the epidemic were similar to those early in the
outbreak in the absence of vaccination campaigns. The sec-
ond way the assumption may be violated is if the campaign
itself reduced the attack rate in the remaining susceptible indi-
viduals in the targeted age class through herd immunity.
Although this cannot be explicitly discounted, this herd
immunity effect would result in positive bias in the estimate
of the campaign impact.
Outbreak response in populations with heterogeneous
immunity
We developed a simple simulation model to illustrate the
role of heterogeneous immunity, such as might arise because
of differences in access to vaccination services or because of
groups that refuse routine vaccination, in the context of an
outbreak response. Consider a population of size N divided
into the following 2 groups: those with high access to vacci-
nation (i.e., high immunity), Nhigh, and those with low access
to vaccination (i.e., low immunity), Nlow. Note that, although
we motivate this model in terms of groups that differ in their
access to vaccination, this framework would apply broadly to
any setting in which the population can be dichotomized into
groups with high and low levels of immunity.
For an outbreak response vaccination campaign with a
goal of θ coverage, we consider 3 scenarios for the correlation
between vaccination in the campaign and the following ac-
cess categories: 1) nonselective“random”vaccination, 2) non-
selective “current” vaccination, and 3) targeted vaccination.
The ﬁrst scenario reﬂects the presumption that the outbreak
response vaccination is nonselective with respect to access.
In this case, individuals in the 2 groups will be vaccinated at
random, and the ﬁnal coverage rates in both groups (θhigh and
θlow, respectively) will be the same, θ = θhigh = θlow.
In the second scenario, which better reﬂects current vacci-
nation strategies, individuals in the high-access group are
more likely to be vaccinated ﬁrst. In this case, we would
expect only individuals in the low-access group to be vacci-
nated if the target coverage is greater than the proportion of
the population in the high-access group (i.e., θhigh ≥ θlow);
then, coverage in the low-access group would reﬂect only
those doses remaining after full vaccination of the high-
access group. If individuals in the high-access group were
preferentially vaccinated before the low-access group, then
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Figure 1. A) The ratio of cases in the targeted and nontargeted age classes after a reference date to before a reference date. Box plots indicate the
interquartile range of the case ratios in 20 noncampaign districts inMalawi as a function of the epidemic week used as the reference time point; white
lines indicate themedian. Grey circles indicate the case ratios for the 8 districts with outbreak response vaccination campaigns with the start week of
the campaign as the reference date. B) Estimated effective campaign coverage for outbreak response vaccination campaigns conducted by Méde-
cins sans Frontiers (Geneva, Switzerland) in 8 districts in Malawi in 2010.
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the ﬁnal coverage in each group would be as follows:
if θ  NhighN
θhigh ¼ θ=ðNhigh=NÞ
θlow ¼ 0

if θ> NhighN
θhigh ¼ 1
θlow ¼ ðθ ðNlow=NÞÞ=ðNhigh=NÞ:

The marginal beneﬁt of vaccination in the high-access group
is necessarily lower than in the low-access group. Thus, an
idealized scenario would be a targeted campaign that ﬁrst
vaccinated the low-access group and then the high-access
group (i.e., θlow ≥ θhigh). If individuals in the low-access
group were preferentially vaccinated before those in the
high-access group, then the ﬁnal coverage in each group
would be as follows:
if θ  NlowN
θlow ¼ θ=ðNlow=NÞ
θhigh ¼ 0

if θ> NlowN
θlow ¼ 1
θhigh ¼ ðθ ðNhigh=NÞÞ=ðNlow=NÞ:

These 3 vaccination scenarios represent idealized versions of
the presumed, worst-case, and best-case vaccination scenar-
ios.
We simulated susceptible-infected-recovered–type out-
breaks in a partially vaccinated population divided into
high-access and low-access groups. We assumed that 60%
of individuals in the high-access group had received 1 dose
of measles vaccine with an efﬁcacy of 0.85, and that 40%
of individuals in the high-access group had received both a
ﬁrst and second dose of measles vaccine with an efﬁcacy of
0.99. We assumed that 50% of individuals in the low-access
group had received 1 dose of measles vaccine with an efﬁ-
cacy of 0.85 and no second dose. Thus, simulations with a
high proportion of hard-to-reach individuals have more sus-
ceptible individuals initially and a higher effectiveR, where R
is the expected number of secondary infections due to each
infectious individual in a partially immune population. We
note that these proportions are not intended to reﬂect any par-
ticular population; rather, this is a heuristic example intended
to illustrate the impact of variations in access to vaccination
on campaign outcomes. In the analysis below, we present re-
sults for simulated populations that vary in the proportion of
individuals in the high-access groups. We provide an analysis
of the sensitivity to the proportion of individuals in the low-
access groups receiving a ﬁrst dose of vaccine (Web Figure 1,
available at http://aje.oxfordjournals.org/), the proportion of
individuals in the high-access groups receiving a second dose
of vaccine (Web Figure 2), and the basic reproductive ratio
(R0) (Web Figure 3).
The epidemiologic characteristics were assumed to be
measles-like, with a basic reproductive ratio, R0, of approxi-
mately 20, a 6-day exposed class following infection in
which individuals were not infectious, and an 8-day infec-
tious period (10). The transmission rate was assumed to be
mildly seasonal, with a sinusoidal seasonal pattern. Out-
breaks were simulated by using a discrete time, stochastic
susceptible-exposed-infectious-removed model; equation
5 gives the expected value of each compartment in the
model, conditional on the value of all states at the previous
time. Stochastic realizations of the epidemic through time
were generated by using the τ-leaping algorithm (11). Fol-
lowing exposure, individuals are modeled as progressing
through three 2-day-long stages in the exposed class and
four 2-day-long stages in the infected class; this formulation
yields a distribution of exposed and infectious periods that is
gamma distributed rather than exponentially distributed with
mean durations of 6 and 8 days, respectively (10). In each
access class, St and Et are the numbers of susceptible and
exposed individuals, respectively, at time t. For the high-
access or low-access class, Ij,in,t and Ij,out,t are the numbers
of infected individuals (in each of the infectious stages
indexed by j) within that class and in the other class, respec-
tively. We assumed homogenous mixing within the 2 access
groups, but that the rate of mixing between the high-access
and low-access groups was half that of the within-group
rate. We assessed the sensitivity of the results to this assumed
mixing pattern by running simulations with a well-mixed
population (no difference between within-group and between-
group mixing) and a population with highly assortative
mixing (between-group mixing rate that was 25% of the
within-group mixing rate) (Web Figures 4 and 5).
Stþ1 ¼ St  βSt
X4
j¼1 ðI j;in;t þ :5I j;out;tÞ
E1tþ1 ¼ E1t þ βSt
X4
j¼1 ðI j;in;t þ :5I j;out;tÞ  ϕE
1
t
E2tþ1 ¼ E2t þ ϕE1t  ϕE2t
E3tþ1 ¼ E3t þ ϕE2t  ϕE3t
I1tþ1 ¼ I1t þ ϕE3t  γI1t
I2tþ1 ¼ I2t þ γI1t  γI2t
I3tþ1 ¼ I3t þ γI2t  γI3t
I4tþ1 ¼ I4t þ γI3t  γI4t
Rtþ1 ¼ Rt þ γI4t :
ð5Þ
We simulated epidemics according to the model above with a
14-day vaccination campaign (outbreak response vaccina-
tion) starting between days 20 and 100 of the outbreak (note
the seasonal peak of transmission was on day 88). We sim-
ulated 3 levels of target vaccination coverage (80%, 90%, and
99%) and calculated the impact of the campaign as the num-
ber of cases averted as a percentage of the case burden from a
simulation with no intervention.
RESULTS
Estimating effective campaign impact
Despite a target coverage of 95% of the population aged 6
months to 15 years, the effective coverage (the proportion of
the susceptible population immunized by the campaign) of
the 2010 nonselective vaccination campaigns was estimated
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to range from −1% in Machinga, where there was a greater
proportion of cases in the targeted age group after the cam-
paign, to 50% in Balaka (Figures 1A and 1B).
Only the ratios for Lilongwe, Mangochi, and Balaka fell
outside the interquartile range for all noncampaign districts
across all weeks (excluding early and late weeks in which
low case numbers contributed to high variability). This sug-
gests that the reduction in cases in the age groups targeted by
vaccination in these districts is unlikely to be due to random
variation, but rather to successful targeting of susceptible
individuals. The observations in the other districts were
within the range of variation for noncampaign districts at
the time; thus, there is no evidence that the observed reduc-
tion of cases in the targeted age class was due to the campaign
itself.
Outbreak response in populations with heterogeneous
access to vaccination
In the random scenario, in which both the high-access
group and the low-access group are vaccinated at equal rates,
the impact of the campaign, measured as the proportion of
cases averted relative to a no-campaign simulation, increases
for campaigns that are conducted early in the outbreak and for
settings where the hard-to-reach population is small (Fig-
ures 2A, 2D, and 2G). Though not surprising, this result serves
as a baseline against which to evaluate the other scenarios.
Campaigns that are biased toward those with previous high
access to vaccination always achieve lower impacts than cam-
paigns that are random with respect to prior access (Fig-
ures 2B, 2E, and 2H). In particular, when the campaign
target coverage is smaller than the proportion of the popula-
tion that is in the low-access class, the expectation is that the
current scenario (i.e., biased toward those with prior access)
would achieve very low effective coverage in this group and
would, thus, have only limited impact (Figures 2B and 2E).
If, however, the campaign target is high enough, the limita-
tion of the current scenario is mitigated (Figure 2H).
Conversely, targeted campaigns that are biased toward
those with low access to vaccination always achieve higher
impacts than either of the other scenarios (provided the cam-
paigns are not too late to be effective). Targeted campaigns,
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Figure 2. The impact of simulated vaccination campaigns (colors indicate cases averted as a proportion of cases in a noncampaign simulation;
scale bar at right) as a function of the timing of the start of the campaign (x-axis) and the proportion of the population in the hard-to-reach class (y-
axis). Rows indicate the target coverage of the campaign (top row is 80%, middle row is 90%, and bottom row is 99% of target population), and
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although logistically difﬁcult, are highly effective, even for
relatively low target coverage (Figure 2C), and they allow
high impact with relatively late implementation (e.g., 90%
cases averted for campaigns implemented 30 days later than
the random vaccination scenario) (Figure 2).
We note that the qualitative simulation results are not
changed when we assume alternative mixing patterns (well-
mixed or assortative) (Web Figure 4). We further ran simula-
tions in which the time required to conduct a campaign was
positively correlated with the target coverage; we assumed 7
days to achieve 50% coverage increasing linearly to 14 days
to achieve 99% coverage. These simulations did not affect the
qualitative results of the comparison among campaign types
(Web Figure 5).
DISCUSSION
In Malawi, the effective impact of the reactive vaccination
campaigns implemented by the Ministry of Health/MSF was
much lower than expected considering the high vaccine cov-
erage achieved. Only 3 districts (Lilongwe, Mangochi, and
Balaka) of the 8 where campaigns were conducted had a
reduction in measles cases in the targeted age groups com-
pared with nontargeted age groups greater than those ob-
served in nonvaccinated districts.
However, because all models are an approximation of real-
ity, the low effective impact reported here may also be due to
uncertainties and gaps in the reported time series of cases.
Measles surveillance in Malawi is based on individual-
based case records, and only the ﬁrst cases are laboratory con-
ﬁrmed. Only districts where the Ministry of Health/MSF
intervened beneﬁtted from reinforced surveillance; therefore,
the degree of bias in districts without this support is un-
known. Further, because these data were used to inform the
model, the effective impact of the reactive campaigns may be
more variable within and between districts. Reported vacci-
nation coverage in Malawi prior to the epidemic in 2010
was high countrywide, with variations in coverage by district,
although in subsequent coverage surveys conducted after the
intervention, coverage was estimated to be insufﬁcient (6).
Several reasons could explain this, including the timeliness
and the choice of targeted age groups. As previously de-
scribed, in some districts of Malawi, reactive campaigns
were implemented late in the course of the outbreak, and only
children aged 6 months to 15 years were targeted, despite the
fact that more than one-third of cases were reported in older
individuals (6).
Further, a likely explanation of the low effective impact of
the vaccination campaigns in Malawi is that susceptible indi-
viduals were not vaccinated. Though the campaigns were as-
sumed to reach everybody at the same time (as in the random
scenario in the simulations above), the Ministry of Health/
MSF mass vaccination campaign in Malawi was likely to
preferentially vaccinate groups with good access to routine
immunization before hard-to-reach groups (as in the current
scenario in the simulations above).
The impact of a vaccination campaign is multifactorial,
depending on the goal of the campaign, timing, population
targeted, quality of the implementation, and prior coverage.
Nevertheless, successful campaigns have high proportions
of individuals who receive their ﬁrst doses of vaccine,
thereby reaching the hard-to-reach populations. Our study
shows that a selective campaign preferentially targeting
hard-to-reach individuals would be of greater beneﬁt, partic-
ularly in settings where vaccine coverage is high, such as
Malawi.
Hard-to-reach individuals may remain unvaccinated when
neither health services nor conventional communication
mechanisms regularly reach their communities. Here, we
have presented a simplistic model with only 2 levels of access
to vaccination. In practice, access to vaccination is likely to
vary on a continuum. Low immunization rates are associated
with communities that are located a long distance from health
services (12), those with little access or exposure to large-
scale or local media (13), those with low doctor-patient and
nurse-patient ratios (14), and those with strong philosophical
or religious objections to vaccination (15). If such covariates
of prior vaccination can be identiﬁed, then targeted strategies
can be developed on the basis of population metrics rather
than the characteristics of individual vaccinees. Such strate-
gies to improve vaccine coverage are likely to be highly con-
text speciﬁc, ranging from enhanced outreach activities for
segregated communities or nomadic populations to high-
quality communication campaigns tailored to meet the infor-
mational needs of vulnerable groups (15).
The proportion of the population effectively immunized
against measles and the age distribution of cases during out-
breaks depend on the performance of national routine control
programs and vary from one country to another, ranging from
stable countries with high measles vaccine coverage to post-
conﬂict countries with disrupted immunization programs and
low vaccine coverage (16). In settings with low levels of im-
munity, nonselective strategies may remain the most timely,
efﬁcient, and cost-effective approach to supplemental vacci-
nation. However, as routine vaccination programs improve, it
is possible that disparities between high-access and low-
access groups will render nonselective strategies increasingly
inefﬁcient. In such contexts, age-speciﬁc or regional esti-
mates of measles vaccine coverage (e.g., through commu-
nity-based surveys) may guide decision-making as to which
high-priority groups to target. Ultimately, innovative out-
reach strategies targeted to reach individualswho are excluded
or beyond the reach of routine immunization services will be
the key to achieving high levels of population immunity and
minimizing the risk of measles resurgence.
In our model, we have taken the proportion of cases
averted as the unique measure of the impact of intervention.
The proportion of deaths averted would have been a more rel-
evant indicator to evaluate the impact of the intervention on
the health of young children. However, in Malawi, measles-
related deaths reported by the surveillance system were few,
so it was not possible to measure the proportion of deaths
averted. Rates of measles-speciﬁc mortality are difﬁcult to
determine in settings with weak vital registration systems.
The impact of a supplemental mass vaccination campaign
is variable and may be lower than expected because of pop-
ulation heterogeneity in immunity and the naïve presumption
that the campaign is nonselective with respect to the immune
status of individuals. Although logistically challenging, tar-
geted campaigns achieve higher impacts, even when target
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coverage is low and implementation is late, and they are the
most effective strategy, particularly in highly vaccinated pop-
ulations. However, the choice between targeted and nonse-
lective campaigns should be context speciﬁc, achieving a
reasonable balance between feasibility, cost, and expected
impact. Indeed, targeted campaigns may introduce additional
trade-offs; although a targeted campaign may vaccinate im-
mune individuals, if not well implemented, it may also result
in fewer people being immunized. Irrespective of the strategy
selected, reinforcement of surveillance and investigation of
local epidemiologic data to guide the decision are essential.
Finally, comprehensive ﬁeld evaluations of the speciﬁc local
factors exacerbating poor access should be encouraged, as
well as postintervention evaluations. Developing operational
strategies to identify and target individuals and subpopula-
tions with low levels of vaccination is paramount to ensuring
the effectiveness of future interventions.
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